ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,151Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 96

$453K Total Retail Price of All Prescriptions

Rank: 28 out of 96

317 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 317 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

21% of this provider’s 317 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,931 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $95 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
FUROSEMIDE 358 329 1 5
HYDROCODONE-ACETAMINOPHEN 314 302 S3 2 1
POTASSIUM CHLORIDE 284 267 3 15
LEVOTHYROXINE SODIUM 245 235 4 6
OXYCODONE HCL-ACETAMINOPHEN 236 199 S2 5 52
WARFARIN SODIUM 224 219 6 14
OMEPRAZOLE 213 187 7 9
PREDNISONE 212 181 8 27
DONEPEZIL HCL 198 198 9 26
OXYCODONE-ACETAMINOPHEN 189 154 S2 10 47
METOPROLOL TARTRATE 177 167 11 12
AMLODIPINE BESYLATE 169 128 12 4
CITALOPRAM HBR 151 136 13 24
SINGULAIR 140 67 14 80
TRAZODONE HCL 136 125 15 37
LANTUS 128 106 16 58
QUETIAPINE FUMARATE 128 126 16 64
LISINOPRIL 127 109 18 2
SODIUM CHLORIDE 121 121 19 233
SERTRALINE HCL 120 89 20 31
GABAPENTIN 110 94 21 8
MONTELUKAST SODIUM 101 46 22 126
SIMVASTATIN 92 81 23 3
MIRTAZAPINE 89 89 24 73
OXYCODONE HCL 89 61 S2 24 76
IPRATROPIUM-ALBUTEROL 88 86 26 260
FENTANYL 81 73 S2 27 77
RISPERIDONE 80 80 28 43
CYMBALTA 80 65 28 62
CEFTRIAXONE 72 69 30 225
FLUTICASONE PROPIONATE 71 42 31 67
SEROQUEL 71 68 31 151
LACTULOSE 71 71 31 186
TAMSULOSIN HCL 70 62 34 51
CARVEDILOL 70 70 34 13
ALLOPURINOL 64 57 36 44
NOVOLIN R 64 64 36 289
ISOSORBIDE MONONITRATE ER 63 63 38 21
ADVAIR DISKUS 62 24 39 60
AZITHROMYCIN 61 56 40 66
SPIRIVA 59 54 41 38
BUSPIRONE HCL 57 36 42 171
CIPROFLOXACIN HCL 57 45 42 79
SYMBICORT 56 48 44 112
NAMENDA 55 55 45 35
METOCLOPRAMIDE HCL 53 28 46 99
MEGESTROL ACETATE 53 50 R 46 311
NOVOLOG 53 41 46 103
DIVALPROEX SODIUM 52 52 49 90
FAMOTIDINE 51 51 50 159
TRAMADOL HCL 50 50 51 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.